Zhejiang Huahai Pharmaceutical Co (SHSE:600521) Short Interest


SHSE:600521 Zhejiang Huahai Pharmaceutical Co Ltd SHSE:600521
82 GF Score
Price ¥16.26
GF Value ¥16.38
Valuation Fairly Valued
! 8 Warning Signs
View Full Analysis

What is Zhejiang Huahai Pharmaceutical Co Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

SHSE:600521 vs ZTS, UTHR: Short Interest Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Zhejiang Huahai Pharmaceutical Co's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Zhejiang Huahai Pharmaceutical Co Short Interest vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zhejiang Huahai Pharmaceutical Co's Short Interest distribution charts can be found below:

* The bar in red indicates where Zhejiang Huahai Pharmaceutical Co's Short Interest falls into.


SHSE:600521
82GF Score
Zhejiang Huahai Pharmaceutical Co Ltd SHSE:600521
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Zhejiang Huahai Pharmaceutical Co (SHSE:600521) Overvalued in 2026?

Based on GuruFocus' analysis, Zhejiang Huahai Pharmaceutical Co stock appears to be undervalued. The current stock price of ¥16.26 is trading 0.7% below its estimated GF Value™ of ¥16.38. GuruFocus considers Zhejiang Huahai Pharmaceutical Co to be Fairly Valued.

Key valuation signals for SHSE:600521:

  • Short Interest:
  • GF Value™: ¥16.38 vs. price of ¥16.26 (0.7% below fair value)
  • GF Score™: 82/100 with 8 warning signs

No single metric tells the full story. See the SHSE:600521 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Zhejiang Huahai Pharmaceutical Co Business Description

Address Xunqiao, Zhejiang Province, Linhai, CHN, 317024
Zhejiang Huahai Pharmaceutical Co Ltd is engaged in research and development, production, and sales of multi-dosage preparations, biological drugs, innovative drugs, and specialty APIs. The company's products include irbesartan hydrochlorothiazide tablets, losartan potassium tablets, paroxetine hydrochloride tablets, sertraline hydrochloride tablets, linagliptin tablets, dabigatran etexilate capsules, pemetrexed disodium for injection, esomeprazole magnesium enteric-coated capsules, torsemide injection, and others.
82GF Score

Get the complete analysis for SHSE:600521

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥16.26
Price
¥16.38
GF Value